APTIMMUNE
Aptimmune is a biotechnology company that focuses on developing a muscoal vaccine against viral diseases swine. It focuses on swine vaccines and the prevention of two major diseases, Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and influenza. It utilizes novel technologies to create effective nasal delivery vaccines against PRRSV such as the proprietary pig alveolar macrophage cell line ZMAC. The company was founded in 2010 and headquartered in St. Louis, Missouri.
APTIMMUNE
Industry:
Biopharma Biotechnology Health Care Health Diagnostics Test And Measurement
Founded:
2010-01-01
Address:
St Louis, Missouri, United States
Country:
United States
Website Url:
http://www.aptimmune.com
Total Employee:
1+
Status:
Active
Contact:
2173334050
Total Funding:
8.85 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Font API WordPress Google Analytics Google Universal Analytics Sitelinks Search Box Yoast WordPress SEO Plugin Yoast Plugins
Similar Organizations
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Stingray Bio
Stingray Bio is ab biotechnology company that targets LMTK3 kinase to develop precision therapeutics for treating cancer.
Current Advisors List
Board_member
Board_member
Current Employees Featured
Federico Zuckermann Founder & Chief Scientific Officer @ Aptimmune
Founder & Chief Scientific Officer
2010-04-01
Heather Bessoff CEO @ Aptimmune
CEO
Steven Berger Development Director @ Aptimmune
Development Director
Gary Durack Director of Operations @ Aptimmune
Director of Operations
Founder
Investors List
The Yield Lab Asia Pacific
The Yield Lab Asia Pacific investment in Convertible Note - Aptimmune
Kemin Industries
Kemin Industries investment in Corporate Round - Aptimmune
Missouri Technology Corporation
Missouri Technology Corporation investment in Series B - Aptimmune
St. Louis Arch Angels
St. Louis Arch Angels investment in Series B - Aptimmune
Cultivation Capital
Cultivation Capital investment in Series B - Aptimmune
Arsenal Capital Management
Arsenal Capital Management investment in Series B - Aptimmune
The Yield Lab
The Yield Lab investment in Series B - Aptimmune
The Yield Lab
The Yield Lab investment in Convertible Note - Aptimmune
Fox Ventures
Fox Ventures investment in Series A - Aptimmune
Illinois Ventures
Illinois Ventures investment in Series A - Aptimmune
Official Site Inspections
http://www.aptimmune.com
- Host name: 196.109.196.104.bc.googleusercontent.com
- IP address: 104.196.109.196
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Aptimmune"
Our Team - Aptimmune
At Aptimmune, Dr. Calzada leads research and vaccine development of novel mucosal vaccines. She works closely with international consultants, Contract Research Organizations and …See details»
Aptimmune - Crunchbase Company Profile & Funding
Aptimmune is a biotechnology company that specializes on developing mucosal vaccines for swine.See details»
Aptimmune Biologics, Inc. Company Profile | Saint Louis, MO ...
Find company research, competitor information, contact details & financial data for Aptimmune Biologics, Inc. of Saint Louis, MO. Get the latest business insights from Dun & Bradstreet.See details»
Aptimmune Biologics - Org Chart, Teams, Culture & Jobs | The Org
View Aptimmune Biologics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Aptimmune 2025 Company Profile: Valuation, Funding & Investors …
Information on valuation, funding, cap tables, investors, and executives for Aptimmune. Use the PitchBook Platform to explore the full profile.See details»
Aptimmune - Contacts, Employees, Board Members, Advisors
Aptimmune has 4 current employee profiles, including Founder & Chief Scientific Officer Federico Zuckermann. Aptimmune has 2 board members and advisors, including Robert (Bob) Easter.See details»
Aptimmune Company Profile - Office Locations, Competitors
See insights on Aptimmune including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Aptimmune Biologics - VentureRadar
Aptimmune Biologics specializes in the development and application of prophylactic measures against viral diseases of swine. Our current focus is bringing into the market effective …See details»
Aptimmune Biologics, Inc. - F6S
Aptimmune Biologics, Inc. - Aptimmune employs our proprietary Barricade technology platform to develop vaccines against the most virulent and economically challenging diseases in animal …See details»
Join Our Team - Aptimmune
Open Position: Scientist Who We Are: Aptimmune Biologics specializes in developing revolutionary mucosal vaccines that provide unsurpassed efficacy against the viral diseases …See details»
Aptimmune - Funding, Financials, Valuation & Investors
Aptimmune is a biotechnology company that specializes on developing mucosal vaccines for swine.See details»
Aptimmune Biologics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Aptimmune Biologics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Aptimmune - Updates, News, Events, Signals & Triggers
Aptimmune may be growing as indicated by its involvement in the development of a vaccine for swine, which is now being discussed as safe and effective. The company has provided a …See details»
Aptimmune Biologics - VentureRadar
"Aptimmune Biologics specializes in the development and application of prophylactic measures against viral diseases of swine. Our current focus is bringing into the market effective …See details»
Aptimmune Biologics | F6S
After securing an exclusive license for the patented ZMAC cell line technology from UIUC, Aptimmune developed and launched its Barricade® Autogenous PRRSv and IAV-S vaccines …See details»
Investors - Aptimmune
To expedite product development, testing and speed-to-market, Aptimmune has established partnerships with major vaccine development and swine health consulting companies.See details»
Aptimmune Biologics - Overview, News & Similar companies
Aug 6, 2018 View Aptimmune Biologics (www.aptimmune.com) location in Illinois, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Mucosal Vaccines - Aptimmune
Aptimmune’s revolutionary mucosal vaccines provide advantages over conventional injectable vaccines currently on the market. How Aptimmune’s mucosal vaccines work:See details»
Altimmune Announces Initiation of RECLAIM Phase 2 Trial
1 day ago Altimmune Announces Initiation of RECLAIM Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol Use Disorder (AUD) May 19, 2025 07:30 ET | Source: …See details»
Barricade Showcase - Aptimmune
Aptimmune’s patented porcine macrophage cell line, ZMAC, is a unique cornerstone in our Barricade Technology Platform. ZMAC is a scalable cell line that specializes in efficiently …See details»